Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.08 Down 0.11(2.12%) 3:59PM EDT
|After Hours : 5.12 Up 0.04 (0.79%) 7:50PM EDT
Prev Close:5.19
Open:5.00
Bid:5.06 x 200
Ask:N/A
1y Target Est:11.63
Beta:1.78
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:4.95 - 5.13
52wk Range:4.60 - 7.82
Volume:4,283,673
Avg Vol (3m):2,276,270
Market Cap:590.94M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 2.12%590.94M
ABTUp 0.26%64.37B
GSKUp 0.92%116.42B
RHHBYUp 0.75%250.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):176.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Jun-14) :-0.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback